Tumor regression grades:Potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy

被引:1
作者
Yi-Fan Peng [1 ]
Wei-Dong Yu [2 ]
Hong-Da Pan [1 ]
Lin Wang [1 ]
Ming Li [1 ]
Yun-Feng Yao [1 ]
Jun Zhao [1 ]
Jin Gu [1 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Colorectal Surgery, Peking University Cancer Hospital and Institute
[2] Institute of Clinical Molecular Biology, People’s Hospital, Peking University
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金; 北京市自然科学基金;
关键词
Tumor regression grade; Preoperative radiotherapy; Rectal adenocarcinoma; Disease-free survival;
D O I
暂无
中图分类号
R735.37 [];
学科分类号
100214 ;
摘要
AIM:To analyze tumor regression grade(TRG)for prognosis of locally advanced rectal adenocarcinoma(LARA)treated with preoperative radiotherapy.METHODS:One hundred and ninety patients with clinical stageⅡ/ⅢLARA were studied.All patients underwent radical surgery(between 2004 and 2010)after 30-Gy/10-fraction preoperative radiotherapy(preRT).All 190 patients received a short course of preRT and were reassessed for disease recurrence and survival;the slides of surgical specimens were reviewed and classified according to Mandard TRG.We compared patients with good response(Mandard TRG1 or TRG2)vs patients with bad/poor response(Mandard TRG3-5).Outcomes evaluated were 5-year overall survival(OS),5-year disease-free survival(DFS),and local,distant and mixed recurrence.Fisher’s exact test orχ2 test,logrank test and proportional hazards regression analysis were used to calculate the probability that Mandard TRG was associated with patient outcomes.RESULTS:One hundred and sixty-six of 190 patients(87.4%)were identified as Mandard bad responders(TRG3-5).High Mandard grade was correlated with tumor height(41.7%<6 cm vs 58.3%≥6 cm,P=0.050),yp T stage(75%yp T0-2 vs 25%yp T3-4,P=0.000),and yp N stage(75%yp N0 vs 25%yp N1,P=0.031).In univariate survival analysis,Mandard grade bad responders had significantly worse OS and DFSthan good responders(TRG1/2)(OS,83.1%vs 96.4%,P=0.000;DFS,72.3%vs 92.0%,P=0.002).In multivariate survival analysis,Mandard bad responders had significantly worse DFS than Mandard good responders(DFS 3.8 years(95%CI:1.2-12.2 years,P=0.026).CONCLUSION:Mandard grade good responders had a favorable prognosis.TRG may be a potential predictor for DFS in LARA after pre-RT.
引用
收藏
页码:1851 / 1856
页数:6
相关论文
共 9 条
  • [1] Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy[J]. Chang-Zheng Du, Jin Gu, Department of Colorectal Surgery, Peking University School of Oncology, Fucheng Road 52, Haidian District, Beijing 100142, China Jie Li, Department of Medical Oncology, Peking University School of Oncology, Fucheng Road 52, Haidian District, Beijing 100142, China Yong Cai, Department of Radiotherapy, Peking University School of Oncology, Fucheng Road 52, Haidian Distric
  • [2] Changing patterns of colorectal cancer in China over a period of 20 years[J]. Ming Li, Jin Gu, Department of Surgery, Beijing Cancer Hospital, Peking University School of Oncology, Beijing Institute for Cancer Research, Beijing 100036, China. World Journal of Gastroenterology. 2005(30)
  • [3] Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions)
    Wang, L.
    Zhong, X. -G.
    Peng, Y. -F.
    Li, Z. -W.
    Gu, J.
    [J]. COLORECTAL DISEASE, 2014, 16 (01) : 33 - 39
  • [4] Tumor Regression Grades: Can They Influence Rectal Cancer Therapy Decision Tree?[J] . Marisa D. Santos,Cristina Silva,Anabela Rocha,Eduarda Matos,Carlos Nogueira,Carlos Lopes,Frank A. Frizelle. International Journal of Surgical Oncology . 2013
  • [5] Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy
    Peng, Yifan
    Wang, Lin
    Du, Changzheng
    Gu, Jin
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (12) : 1555 - 1560
  • [6] PATHOLOGIC NODAL CLASSIFICATION IS THE MOST DISCRIMINATING PROGNOSTIC FACTOR FOR DISEASE-FREE SURVIVAL IN RECTAL CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMORADIOTHERAPY AND CURATIVE RESECTION
    Kim, Tae Hyun
    Chang, Hee Jin
    Kim, Dae Yong
    Jung, Kyung Hae
    Hong, Yong Sang
    Kim, Sun Young
    Park, Ji Won
    Oh, Jae Hwan
    Lim, Seok-Byung
    Choi, Hyo Seong
    Jeong, Seung-Yong
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1158 - 1165
  • [7] Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial[J] . David Sebag-Montefiore,Richard J Stephens,Robert Steele,John Monson,Robert Grieve,Subhash Khanna,Phil Quirke,Jean Couture,Catherine de Metz,Arthur Sun Myint,Eric Bessell,Gareth Griffiths,Lindsay C Thompson,Mahesh Parmar. The Lancet . 2009 (9666)
  • [8] The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma[J] . Koen C.M.J. Peeters,Corrie A.M. Marijnen,Iris D. Nagtegaal,Elma Klein Kranenbarg,Hein Putter,Theo Wiggers,Harm Rutten,Lars Pahlman,Bengt Glimelius,Jan Willem Leer,Cornelis J.H. van de Velde. Annals of Surgery . 2007 (5)
  • [9] Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy
    Losi, Lorena
    Luppi, Gabriele
    Gavioli, Margherita
    Iachetta, Francesco
    Bertolini, Federica
    D'Amico, Roberto
    Jovic, Gordana
    Bertoni, Filippo
    Falchi, Anna Maria
    Conte, Pier Franco
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2006, 21 (07) : 645 - 651